澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

syngenta australia pty ltd - brodifacoum - bait - brodifacoum coumarin active 0.05 g/kg - vertebrate poison - agricultural/farm buildings | buildings - around | industrial and/or domestic premises | animal housing | chemical soil barrier - mouse - mus spp. | rat | rat/mouse species resistant to wafarin

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

syngenta australia pty ltd - brodifacoum - bait - brodifacoum coumarin active 0.05 g/kg - vertebrate poison - building - see label | domestic pest control | building - empty | building - vacant | building with forced draught | building wi - mouse - mus spp. | rat

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rentokil initial pty ltd - brodifacoum - bait - brodifacoum coumarin active 0.05 g/kg - vertebrate poison - commercial/industrial premises | domestic building/structure - external a | public service area | external areas and surrounds | - mouse - mus spp.

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

adama australia pty limited - brodifacoum - bait - brodifacoum coumarin active 0.05 g/kg - vertebrate poison - agricultural/farm buildings | commercial/industrial premises | domestic and/or public area | domestic pest control | animal hous - mouse - mus spp. | rat

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioproperties pty. ltd. - salmonella typhimurium - oral solution/suspension - salmonella typhimurium vaccine-microbial active 0.0 undefined - immunotherapy - poultry chicks | turkey poult (young) | chickens | day old chicks | hatchlings | turkeys - day old poults | young turkey - salmonella enteridis | salmonella typhimurium | vaccine | equine rotavirus

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - hepatitis a vaccine 1440 eu/ml;  ; hepatitis a vaccine 1440 eu/ml - suspension for injection - 1440 eu/ml - active: hepatitis a vaccine 1440 eu/ml   excipient: aluminium hydroxide amino acids dibasic sodium phosphate dihydrate monobasic potassium phosphate polysorbate 20 potassium chloride sodium chloride active: hepatitis a vaccine 1440 eu/ml excipient: aluminium hydroxide amino acids dibasic sodium phosphate dihydrate monobasic potassium phosphate phenoxyethanol polysorbate 20 potassium chloride sodium chloride - havrix is indicated for active immunisation against hav infection in subjects at risk of exposure to hav. havrix will not prevent hepatitis infection caused by other agents such as hepatitis b virus, hepatitis c virus, hepatitis e virus or other pathogens known to infect the liver. in areas of low and intermediate prevalence of hepatitis a, immunisation with havrix is particularly recommended in subjects who are, or will be, at increased risk of infection.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - hepatitis a vaccine 1440 eu/ml equivalent to 720 eu/0.5 ml;  ; hepatitis a vaccine 1440 eu/ml equivalent to 720 eu/0.5ml - suspension for injection - 720 elisa u/0.5ml - active: hepatitis a vaccine 1440 eu/ml equivalent to 720 eu/0.5 ml   excipient: aluminium hydroxide amino acids dibasic sodium phosphate dihydrate monobasic potassium phosphate polysorbate 20 potassium chloride sodium chloride active: hepatitis a vaccine 1440 eu/ml equivalent to 720 eu/0.5ml excipient: aluminium hydroxide amino acids dibasic sodium phosphate dihydrate monobasic potassium phosphate phenoxyethanol polysorbate 20 potassium chloride sodium chloride - havrix is indicated for active immunisation against hav infection in subjects at risk of exposure to hav. havrix will not prevent hepatitis infection caused by other agents such as hepatitis b virus, hepatitis c virus, hepatitis e virus or other pathogens known to infect the liver. in areas of low and intermediate prevalence of hepatitis a, immunisation with havrix is particularly recommended in subjects who are, or will be, at increased risk of infection.

以色列 - 英文 - Ministry of Health

glaxo smith kline (israel) ltd - hepatitis a virus antigen, inactivated - suspension for injection - hepatitis a virus antigen, inactivated 1440 e.l.u/ml - hepatitis a, inactivated, whole virus - hepatitis a, inactivated, whole virus - active immunisation against infections caused by hepatitis a virus.the vaccine is particularly indicated for those at increased risk of infection or transmission.

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

leo laboratories limited - bendroflumethiazide; potassium chloride - modified-release tablet - 2.5/573 milligram(s) - thiazides and potassium in combination; bendroflumethiazide and potassium

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

leo laboratories limited - bendroflumethiazide; potassium chloride - modified-release tablet - 1.25/573 milligram(s) - thiazides and potassium in combination; bendroflumethiazide and potassium